This large-scale exploratory study demonstrated that the prevalence of HDV antibody positivity was very low (0.24%) in Chinese patients with chronic HBV infection, with only one of the 4,936 patients ...
Switching to a long-acting cabotegravir/rilpivirine antiretroviral regimen may be safe for patients with HIV who have prior hepatitis B virus exposure, a real-world study shows.
Data demonstrate that BRII-179 (VBI-2601) induced both B cell (antibody) and T cell responses in chronically-infected hepatitis B (HBV) patients, and was well-tolerated with no safety signals observed ...
A three-antigen hepatitis B vaccine (3A-HBV) induced higher hepatitis B surface antibody (anti-HB) concentrations and seroprotection versus the single-antigen vaccine (1A-HBV) in a phase III trial.
A Nature Medicine study links the activation of brain reward pathways to stronger antibody responses after hepatitis B vaccination in healthy adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results